PharmaCielo Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	9	12	14	30	26	146
Market Cap Growth	-49.66%	-13.08%	-52.65%	12.06%	-81.83%	-49.48%
Enterprise Value	27	33	35	46	38	143
Last Close Price	0.05	0.07	0.08	0.18	0.17	0.98
PS Ratio	4.14	3.85	4.04	19.26	4.99	74.96
PB Ratio	-0.63	-1.29	-1.87	-17.68	4.14	7.54
P/TBV Ratio	-	-	-	-	4.14	7.54
EV/Sales Ratio	11.87	10.27	10.04	30.14	7.08	73.75
Debt / Equity Ratio	-1.19	-2.34	-2.73	-10.90	1.97	0.44
Net Debt / Equity Ratio	-1.18	-2.34	-2.71	-10.86	1.92	0.14
Net Debt / EBITDA Ratio	-3.70	-6.51	-4.50	-2.13	-1.16	-0.11
Net Debt / FCF Ratio	-9.05	-13.16	-10.35	-3.53	-1.18	-0.13
Asset Turnover	-	-	0.17	0.07	0.17	0.05
Inventory Turnover	-	-	1.44	1.31	1.94	3.46
Quick Ratio	0.04	0.04	0.04	0.04	0.25	0.77
Current Ratio	0.15	0.10	0.12	0.16	0.58	1.14
Return on Equity (ROE)	-	-	-	-691.70%	-112.89%	-116.87%
Return on Assets (ROA)	-	-	-14.33%	-26.24%	-22.37%	-39.16%
Return on Capital Employed (ROCE)	37.30%	97.00%	164.30%	-1138.80%	-60.20%	-89.90%
Earnings Yield	-69.83%	-74.44%	-65.03%	-54.89%	-54.78%	-18.27%
FCF Yield	-	-13.79%	-14.01%	-17.39%	-39.24%	-14.55%
Buyback Yield / Dilution	-8.73%	-1.96%	-6.83%	-6.03%	-3.67%	-29.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.